Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Fresh insights into how how pig immune system fights flu
"These findings may prove to be crucial for the design of future vaccines against respiratory diseases" - Dr Elma Tchilian.

The findings could lead to new human treatments.

Scientists investigating pigs’ response immune response to influenza have, for the first time, identified specific cells that are crucial in the fight against infection and for providing long-term protection against illness.

In the study, researchers at the Pirbright Institute found four types of T cells that target host cells infected with viruses and kill them to prevent the virus from spreading.

It is hoped that the findings will shed more light on how the human immune system adapts to flu and lead to the development of new vaccines.

Dr Elma Tchilian, head of the mucosal immunology group at Pirbright explains: “These findings may prove to be crucial for the design of future vaccines against respiratory diseases. Tissue resident memory (TRM) cells are important in respiratory diseases such as influenza and COVID-19 and identifying, in detail, where they are located in a relevant animal model is important for our understanding of disease in pigs."

“This knowledge is also highly relevant to human disease. For the first time, we describe the distribution of cells involved in the immune response and their activity over the course of natural infection or vaccination and these are important knowledge gaps to fill.” 

Published in Mucosal Immunology, the study examined the apadative response of CD8 T cells. These are cells that specifically target host cells infected with viruses and kill them to prevent the viruses from spreading.

The team identified four different types of CD8 T cells - naïve, central memory, effector memory and differentiated effector porcine CD8 T cells - and focussed on the tissues where the cells are found. Their results show that the pig immune response is different to that seen in small animals like mice or ferrets, which are not natural hosts for influenza.

The team also revealed the location of D8 T cells in different pig tissues and how they respond to infection. Until now, it was thought that the number of T cells in the lungs declines rapidly after infection, however, this research shows that this is not the case, suggesting longer-lasting protection against future infection. 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.